NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO
THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY JURISDICTION IN WHICH
SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

Zaptec AS - Contemplated secondary placing 

ABG Sundal Collier ASA (the "Manager") has been retained by Valinor AS
("Valinor") to explore the sale of up to approximately 7.4 million existing
shares in Zaptec AS (the "Company" or "Zaptec"), representing approximately 10%
of the share capital in the Company (the "Placing"). The Placing is to be
conducted as an accelerated bookbuilding process.

The bookbuilding process will commence immediately following the publication of
this announcement and may be closed at short notice at the full discretion of
the Manager. A further announcement will be made following pricing of the shares
in the Placing. Valinor reserves the right, at its own discretion, to sell fewer
shares or no shares at all. 

Due to, inter alia, strong interest and the favourable development in the Zaptec
share price and liquidity since the private placement and listing of the Company
on Euronext Growth Oslo on 6 October 2020 (the "Listing"), the Manager has
agreed to waive the 180 days lock-up agreement brought onto Valinor's
shareholding in connection with the Listing for all shares sold as part of the
Placing against a similar lock-up undertaking from Valinor with respect to all
shares not sold as part of the Placing for a period of 180 days from the date of
Placing.

Valinor currently holds 17,424,432 shares in the Company, representing 23.4% of
the share capital in the Company. Valinor is represented on the board of
directors in the Company by Pål Selboe Valseth.

For further information, please contact:
ABG Sundal Collier: +47 22 01 60 11